Heart Failure With Mid-range Ejection Fraction. [PDF]
Curr Heart Fail Rep, 2020 Purpose of reviewTo describe the epidemiology, pathophysiology, management, and prognosis of patients with heart failure with mid-range ejection fraction (HFmrEF).Recent findingsIn 2013, The American Heart Association (AHA)/American College of Cardiology
Fonarow, Gregg C +6 more
core +2 more sources
Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction [PDF]
Frontiers in Cardiovascular Medicine, 2021 Pulmonary hypertension (PH) is common in patients with heart failure (HF). The role of PH in patients with HF with reduced (HFrEF) and preserved (HFpEF) left ventricular ejection fraction (LVEF) has been extensively characterized during the last years ...
Micha T. Maeder +5 more
doaj +2 more sources
The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction [PDF]
Frontiers in Cardiovascular Medicine, 2022 BackgroundPrevious studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Shaohua Guo +7 more
doaj +2 more sources
Heart Failure with Mid-range Ejection Fraction: Lessons from CHARM [PDF]
Card Fail Rev, 2018 The newly defined category of heart failure (HF) with mid-range ejection fraction (HFmrEF; EF 40-49 %) is beginning to be characterised but little is known about the potential for treating it.
Lund, LH
core +2 more sources
Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage? [PDF]
Frontiers in Cardiovascular Medicine, 2021 Heart failure with mid-range ejection fraction (HFmrEF) was first proposed by Lam and Solomon in 2014, and was listed as a new subtype of heart failure (HF) in 2016 European Society of Cardiology guidelines. Since then, HFmrEF has attracted an increasing
Qing Zhou +18 more
doaj +2 more sources
Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction [PDF]
ESC Heart Failure, 2020 Aims Heart failure with mid‐range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms ...
Enrique Santas +9 more
doaj +2 more sources
Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence [PDF]
Frontiers in Cardiovascular Medicine, 2021 Heart failure (HF) is a complex syndrome causing heavy burden in public health, and the modern objective assessment of it is based on the left ventricular ejection fraction (LVEF). In 2016, the European Society of Cardiology classified the “gray area” in
Teng Ma, Yang Su, Jing Song, Dachun Xu
doaj +2 more sources
Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction [PDF]
ESC Heart Failure, 2021 Aims Current evidence about the effect of angiotensin receptor blocker (ARB) on the outcome of heart failure with mid‐range ejection fraction (HFmrEF) is lacking.
Bin Wang +6 more
doaj +2 more sources
Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction [PDF]
ESC Heart Failure, 2020 Aims Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients ...
Nobuyuki Enzan +6 more
doaj +2 more sources
Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition [PDF]
Cardiac Failure Review, 2020 The recent definition of an intermediate clinical phenotype of heart failure (HF) based on an ejection fraction (EF) of between 40% and 49%, namely HF with mid-range EF (HFmrEF), has fuelled investigations into the clinical profile and prognosis of this ...
Davide Margonato +6 more
doaj +2 more sources